Gene therapy trial as a treatment for choroideremia
A clinical trial, funded by the Efficacy and Mechanism Evaluation (EME) programme, an MRC and NIHR partnership, will investigate if a new gene therapy treatment can restore the vision or prevent progressive vision loss for people with choroideremia.Normally affecting males, choroideremia is an inherited disease of the eye leading to progressive loss of sight...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news
More News: American Health | Clinical Trials | Eyes | Gene Therapy | Genetics | National Institute for Health Research (NIHR) | Partnerships | Study